APTARGROUP, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data APTARGROUP, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,331	2,469	2,765	2,860	2,929	3,227	3,322	3,487	3,583	3,777
Cost of revenue								2,224	2,227	2,372
Gross profit	687	723	796	874	906			1,263	1,356	1,405
Research and development	66.2	68.2	75.3	82.8	92.5	99.8	93.5	92.8	96.1	105
Operating income	314	323	286	372	339	347	379	404	496	501
Interest expense	35.2	40.6	32.6	35.5	33.2	30.3	40.8	40.4	43.9	52.7
Interest income	2.64	5.47	7.06	4.17	0.96	3.67	2.7	4.37	12.1	11.7
Other non-operating income	-0.41	6.69	5.55	1.56	-7.68	-3.09	-4.8	3.21	3.27	-2.03
Pre-tax income	280	295	266	342	301	322	335	375	470	491
Income tax	74.9	74.8	71.3	99.8	87.1	78	95.1	90.6	95.6	98.9
Net income to minority interests	0.01	-0	0.02	0.03	0.05	-0.46	0.27	-0.31	-0.36
Net income	206	220	195	242	214	244	239	284	375	393
EBITDA	468	477	458	566	560	582	613	653	760	788
EPS, basic	3.27	3.52	3.12	3.81	3.32	3.72	3.66	4.34	5.65	5.97
EPS, diluted	3.17	3.41	3.00	3.66	3.21	3.61	3.59	4.25	5.53	5.89
Shares, basic (weighted)	62.8	62.4	62.4	63.6	64.4	65.7	65.4	65.6	66.3	65.7
Shares, diluted (weighted)	64.8	64.6	65	66.2	66.7	67.7	66.7	66.9	67.7	66.7
Dividend per share	1.22	1.28		1.42	1.44	1.50	1.52	1.58	1.72	1.83

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	466	713	262	242	300	123	142	224	224	402
Short-term investments				0	0.24	0.74	0	0	2.34	7.11
Receivables	433	510	570	558	567	671	677	678	658	804
Inventory	297	337	381	376	379	441	487	513	462	538
Other current assets	73.8	110	118	115	123	122	125	135	132	142
Total current assets	1,270	1,670	1,331	1,291	1,369	1,358	1,430	1,549	1,478	1,894
Property, plant and equipment	784	868	992	1,088	1,199	1,276	1,344	1,478	1,447	1,676
Lease right-of-use assets			0	72.4	69.8	62.5	58.7	59.1	64.2	65.7
Goodwill	408	444	712	763	899	974	946	963	936	1,078
Intangible assets	94.5	95.5	255	291	344	362	316	283	255	255
Long-term investments		9.44	25.4	8.4	50.1	59.5	52.3	49.2	146	131
Other non-current assets	552	600	1,055	1,183	1,422	1,507	1,430	1,425	1,507	1,683
Total assets	2,607	3,138	3,378	3,562	3,990	4,141	4,203	4,452	4,432	5,253
Accounts payable	116	154	165	193	244	285	320	329	296	341
Accrued liabilities	120	144	168	164	177	195	210	222	211	233
Deferred revenue			68.1	79.3	87.2	86.3	80.2	60.5	64.4	74.8
Short-term debt	4.6	61.8	62.7	66	65.7	142	119	376	162	160
Total current liabilities	543	528	689	683	780	982	917	1,251	1,068	1,166
Long-term debt	773	1,191	1,126	1,085	1,055	907	1,053	681	688	1,139
Lease liabilities			0	55.3	52.2	48	42.9	45.3	49.7	47.9
Total liabilities	1,433	1,826	1,955	1,990	2,139	2,157	2,135	2,131	1,946	2,567
Total debt	777	1,253	1,189	1,151	1,121	1,049	1,172	1,058	850	1,299
Paid-in capital	547	609	679	771	849	917	969	1,044	1,126	1,166
Retained earnings	1,197	1,301	1,372	1,524	1,644	1,789	1,929	2,110	2,371	2,643
Treasury stock	-251	-346	-318	-381	-362	-421	-503	-539	-596	-954
Other comprehensive income	-320	-253	-311	-342	-282	-316	-341	-309	-429	-186
Shareholders' equity	1,174	1,312	1,423	1,572	1,850	1,969	2,054	2,307	2,472	2,668
Minority interests	0.29	0.31	0.32	0.34	0.4	15.2	14.3	14.5	14	17.9
Total equity	1,174	1,312	1,423	1,572	1,851	1,985	2,068	2,321	2,486	2,686
Total liabilities and equity	2,607	3,138	3,378	3,562	3,990	4,141	4,203	4,452	4,432	5,253

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	206	220	195	242	214	244	240	284	374	392
Depreciation and amortization	155	153	172	195	220	235	234	249	264	287
Stock-based compensation	19.8	18.9	19.6	23.9	34.1	38.9	40.9	41.3	47.7	43.9
Deferred income tax	-11.1	2.24	-23.4	8.75	-8.2	-14.4	-12.1	-19.9	-21.4	-11.7
Change in receivables	-41.7	-44.7	-67	8.81	13.5	-123
Change in inventory	-0.83	-13	-25.2	0.61	13.7	-80	-60.4	-10.6	21.9	-10.6
Change in payables	-12.5	58.2	60.6	10	65.6	52.3	55.1	14.6	-23.7	-18.3
Cash from operations	325	325	314	514	570	363	479	575	643	570
Capital expenditures	-129	-157	-211	-242	-246	-308	-310	-312	-276	-270
Acquisitions	-203		-528	-106	-164	-148	-4.1	-16.6	0	-60.2
Purchases of investments		-5	-10	-3.53	-39.6	-6.87	0	0	-2.24
Cash from investing	-301	-225	-735	-336	-452	-457	-296	-324	-397	-331
Debt issued	5.96	626	13.2	10.5	4.85	11.7	412	0.4	169	600
Debt repaid	-55.3	-166	-72.3	-67.3	-64.7	-68.8	-265	-126	-374	-167
Stock issued	55.3	73.9	88.2	90.8	68.6	59.9	28.5	54	54.8	18.9
Share buybacks		-121	-3.91	-86.5	0	-78.1	-92.1	-47.6	-68.6	-365
Dividends paid	-76.7	-79.9	-82.3	-90.2	-92.7	-98.5	-99.5	-104	-114	-121
Cash from financing	-29.7	115	-14.9	-197	-73.7	-81.5	-162	-172	-225	-77.5
Exchange rate effect	-18.7	31.6	-9.11	-0.9	13.5	-6.73	-1.07	2.19	-21.1	19.4
Net change in cash	-23.6	246	-446	-19.9	58	-182	19.8	81.4	0.2	181
Free cash flow	196	168	102	272	324	55.5	168	263	367	300
Interest paid	36.3	38.8	32	34.4	33.3	29.1	35.5	39.6	43.5	50
Income taxes paid	82.2	77.3	96	86.1	93.6	95	87.5	112	89.4	179

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $123.87 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.1%	Gross profit / revenue.
Operating margin	12.1%	Operating income / revenue.
EBITDA margin	19.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.6%	Pre-tax income / revenue.
Net margin	9.2%	Net income / revenue.
FCF margin	7.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	14.8%	Cash from operations / revenue.
Effective tax rate	20.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	13.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.1%	Net income / average total assets.
Return on invested capital (ROIC)	10.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	6.9%	Capital expenditures / revenue.
D&A / revenue	7.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 5y	9.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	0.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	9.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	8.1%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	3.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	8.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	7.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	4.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	18.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	12.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	6.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	17.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	12.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-11.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-18.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	21.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-1.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	6.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	6.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	9.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	18.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.61x	Current assets / current liabilities.
Quick ratio	0.96x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.17x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.44x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	22.4%	Total debt / total assets.
Liabilities / assets	48.4%	Total liabilities / total assets.
Net debt	$952.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.25x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.52x	Operating income / interest expense.
Working capital	$698.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	25.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.32B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.77x	Revenue / average total assets.
Fixed asset turnover	2.39x	Revenue / average property, plant and equipment.
Inventory turnover	4.33x	Cost of revenue / average inventory.
Days inventory	84 days	365 x average inventory / cost of revenue.
Receivables turnover	4.38x	Revenue / average receivables.
Days sales outstanding	83 days	365 x average receivables / revenue.
FCF conversion	85.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	46.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.65	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$61.26	Revenue / diluted weighted shares.
FCF per share	$4.83	Free cash flow / diluted weighted shares.
Operating cash flow per share	$9.09	Cash from operations / diluted weighted shares.
Book value per share	$40.93	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$20.63	Tangible book value / shares outstanding.
Cash per share	$3.07	(Cash + short-term investments) / shares outstanding.
Payout ratio	33.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	39.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	117.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$7.88B	Share price x shares outstanding.
Enterprise value	$8.83B	Market cap + total debt - cash - short-term investments.
P/E	21.7x	Market cap / net income. Only when net income is positive.
P/S	2.00x	Market cap / revenue.
P/B	3.00x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.94x	Market cap / tangible book value, when positive.
P/FCF	25.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	13.5x	Market cap / cash from operations, when positive.
EV/Sales	2.24x	Enterprise value / revenue.
EV/EBIT	18.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	28.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.9%	Free cash flow / market cap.
Earnings yield	4.6%	Net income / market cap (the inverse of P/E).
Dividend yield	1.6%	Dividends paid over the period / market cap.
Shareholder yield	6.2%	(Dividends paid + share buybacks) / market cap.
PEG	1.21x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was APTARGROUP, INC.'s revenue in fiscal 2025?

APTARGROUP, INC. reported revenue of $3.78B for fiscal 2025, 5.4% higher than the year before.

Was APTARGROUP, INC. profitable in fiscal 2025?

Yes. Net income was $392.8M, a net margin of 10.4%.

How much free cash flow did APTARGROUP, INC. generate in fiscal 2025?

Cash from operations of $570.0M minus capital expenditures of $270.4M left free cash flow of $299.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to APTARGROUP, INC.